Lee's Pharmaceutical Holdings Limited (FRA:L1PA)

Germany flag Germany · Delayed Price · Currency is EUR
0.1760
-0.0050 (-2.76%)
At close: Nov 26, 2025
26.62%
Market Cap110.56M
Revenue (ttm)155.81M
Net Income (ttm)10.61M
Shares Outn/a
EPS (ttm)0.02
PE Ratio10.42
Forward PEn/a
Dividend0.01 (2.97%)
Ex-Dividend DateSep 12, 2025
Volumen/a
Average Volumen/a
Open0.1760
Previous Close0.1810
Day's Range0.1760 - 0.1760
52-Week Range0.1310 - 0.2700
Betan/a
RSI38.40
Earnings DateNov 17, 2025

About FRA:L1PA

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to trea... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 1,022
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol L1PA
Full Company Profile

Financial Performance

In 2024, FRA:L1PA's revenue was 1.40 billion, an increase of 32.95% compared to the previous year's 1.05 billion. Earnings were 93.10 million, an increase of 457.55%.

Financial numbers in HKD Financial Statements

News

There is no news available yet.